The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is offering this grant to support the Clinical Trials Transformation Initiative (CTTI). This cooperative agreement is for enhancing the quality and efficiency of clinical trials, a vital aspect of medical research. This is a single-source renewal grant intended for the Duke University’s Duke Clinical Research Institute (DCRI), recognizing its continued expertise and role in the CTTI. The grant aims to foster ongoing improvements in the conduct and outcomes of clinical trials, ultimately contributing to more reliable data and expediting the development of new treatments for public health.
Opportunity ID: 353917
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-24-040 |
| Funding Opportunity Title: | Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Consumer Protection Food and Nutrition |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 01, 2024 |
| Last Updated Date: | May 01, 2024 |
| Original Closing Date for Applications: | Jul 03, 2024 |
| Current Closing Date for Applications: | Jul 03, 2024 |
| Archive Date: | Aug 02, 2024 |
| Estimated Total Program Funding: | $7,500,000 |
| Award Ceiling: | $7,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Duke University |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a Cooperative Agreement to the Duke University’s Duke Clinical Research Institute (DCRI) to support the Clinical Trials Transformation Initiative (CTTI). |
| Link to Additional Information: | RFA-FD-24-040 Funding Opportunity Announcement |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Terrin Brown
Grantor Email:terrin.brown@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Terrin Brown Grantor Email: terrin.brown@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-24-040 | FORM H | PKG00286176 | May 01, 2024 | Jul 03, 2024 | View |
Package 1
Mandatory forms
353917 RR_SF424_5_0-5.0.pdf
353917 PHS398_CoverPageSupplement_5_0-5.0.pdf
353917 RR_OtherProjectInfo_1_4-1.4.pdf
353917 PerformanceSite_4_0-4.0.pdf
353917 RR_KeyPersonExpanded_4_0-4.0.pdf
353917 RR_Budget_3_0-3.0.pdf
353917 PHS398_ResearchPlan_5_0-5.0.pdf
353917 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353917 RR_SubawardBudget30_3_0-3.0.pdf
353917 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
